142 related articles for article (PubMed ID: 8915486)
1. Targeting microtubule-associated proteins in glioblastoma: a new strategy for selective therapy.
Piepmeier JM; Pedersen PE; Yoshida D; Greer C
Ann Surg Oncol; 1996 Nov; 3(6):543-9. PubMed ID: 8915486
[TBL] [Abstract][Full Text] [Related]
2. Estramustine sensitizes human glioblastoma cells to irradiation.
Yoshida D; Piepmeier J; Weinstein M
Cancer Res; 1994 Mar; 54(6):1415-7. PubMed ID: 8137240
[TBL] [Abstract][Full Text] [Related]
3. Selective antimitotic effects of estramustine correlate with its antimicrotubule properties on glioblastoma and astrocytes.
Yoshida D; Cornell-Bell A; Piepmeier JM
Neurosurgery; 1994 May; 34(5):863-7; discussion 867-8. PubMed ID: 8052384
[TBL] [Abstract][Full Text] [Related]
4. Estramustine and estrone analogs rapidly and reversibly inhibit deoxyribonucleic acid synthesis and alter morphology in cultured human glioblastoma cells.
Piepmeier JM; Keefe DL; Weinstein MA; Yoshida D; Zielinski J; Lin TT; Chen Z; Naftolin F
Neurosurgery; 1993 Mar; 32(3):422-30; discussion 430-1. PubMed ID: 8384327
[TBL] [Abstract][Full Text] [Related]
5. Estramustine in malignant glioma.
Bergenheim AT; Henriksson R; Piepmeier JM; Yoshida D
J Neurooncol; 1996 Oct; 30(1):81-9. PubMed ID: 8865006
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced apoptosis by anti-microtubule agent, estramustine phosphate on human malignant glioma cell line, U87MG; in vitro study.
Yoshida D; Hoshino S; Shimura T; Takahashi H; Teramoto A
J Neurooncol; 2000 Apr; 47(2):133-40. PubMed ID: 10982154
[TBL] [Abstract][Full Text] [Related]
7. Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma.
Bergenheim AT; Björk P; Bergh J; von Schoultz E; Svedberg H; Henriksson R
Cancer Res; 1994 Sep; 54(18):4974-9. PubMed ID: 8069865
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitizing effect of estramustine in malignant glioma in vitro and in vivo.
Bergenheim AT; Zackrisson B; Elfverson J; Roos G; Henriksson R
J Neurooncol; 1995; 23(3):191-200. PubMed ID: 7673981
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of cell proliferation, viability, and invasiveness in U87MG human glioblastoma cells by estramustine phosphate.
Yoshida D; Piepmeier JM; Teramoto A
Neurosurgery; 1996 Aug; 39(2):360-6. PubMed ID: 8832674
[TBL] [Abstract][Full Text] [Related]
10. Suppression of matrix metalloproteinase-2-mediated cell invasion in U87MG, human glioma cells by anti-microtubule agent: in vitro study.
Yoshida D; Piepmeier JM; Bergenheim T; Henriksson R; Teramoto A
Br J Cancer; 1998; 77(1):21-5. PubMed ID: 9459141
[TBL] [Abstract][Full Text] [Related]
11. The antineoplastic agent estramustine and the derivative estramustine-phosphate inhibit secretion of interleukin-3 in leukemic cells. Possible roles of MAPs.
Martínez J; Santibáñez JF; Vial C; Maccioni RB
Mol Cell Biochem; 1992 Nov; 117(2):165-73. PubMed ID: 1488050
[TBL] [Abstract][Full Text] [Related]
12. Estramustine: a novel radiation enhancer in human carcinoma cells.
Ryu S; Gabel M; Khil MS; Lee YJ; Kim SH; Kim JH
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):99-104. PubMed ID: 7916009
[TBL] [Abstract][Full Text] [Related]
13. Estrogen mustard induces cell cycle arrest of human epithelial ovarian cancer cell lines.
Nathan JD; Keefe DL; Weinstein MA; Chen Z; Naftolin F
J Soc Gynecol Investig; 1994; 1(1):97-103. PubMed ID: 9419755
[TBL] [Abstract][Full Text] [Related]
14. Interaction of estramustine with tubulin isotypes.
Laing N; Dahllöf B; Hartley-Asp B; Ranganathan S; Tew KD
Biochemistry; 1997 Jan; 36(4):871-8. PubMed ID: 9020786
[TBL] [Abstract][Full Text] [Related]
15. Estramustine resistance.
Sangrajrang S; Calvo F; Fellous A
Gen Pharmacol; 1999 Aug; 33(2):107-13. PubMed ID: 10461848
[TBL] [Abstract][Full Text] [Related]
16. The antimicrotubule drug estramustine but not irradiation induces apoptosis in malignant glioma involving AKT and caspase pathways.
Vallbo C; Bergenheim T; Hedman H; Henriksson R
J Neurooncol; 2002 Jan; 56(2):143-8. PubMed ID: 11995815
[TBL] [Abstract][Full Text] [Related]
17. Estramustine potentiates the radiation effect in human prostate tumor transplant in nude mice.
Eklöv S; Westlin JE; Rikner G; Nilsson S
Prostate; 1994; 24(1):39-45. PubMed ID: 8290388
[TBL] [Abstract][Full Text] [Related]
18. Estramustine-binding protein (EMBP) in renal cell carcinoma immunohistochemistry, immunoscintigraphy and in vitro estramustine effects.
Edgren M; Westlin JE; Letocha H; Nordgren H; Kälkner KM; Nilsson S
Acta Oncol; 1996; 35(4):483-8. PubMed ID: 8695166
[TBL] [Abstract][Full Text] [Related]
19. Preclinical and clinical perspectives on the use of estramustine as an antimitotic drug.
Tew KD; Glusker JP; Hartley-Asp B; Hudes G; Speicher LA
Pharmacol Ther; 1992 Dec; 56(3):323-39. PubMed ID: 1301594
[TBL] [Abstract][Full Text] [Related]
20. Estramustine-binding protein (EMBP) content in four different cell lines and its correlation to estramustine induced metaphase arrest.
Eklöv S; Mahdy E; Wester K; Björk P; Malmström PU; Busch C; Nilsson S
Anticancer Res; 1996; 16(4A):1819-22. PubMed ID: 8712706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
